Pharmadule Morimatsu brings world-leading process design skills to ISPE Europe
Press Release | Pharmadule Morimatsu AB
MARCH 20, 2017
Nacka, Stockholm: – Pharmadule Morimatsu AB, the Swedish-based world-wide turnkey supplier specialist in modular construction, facility engineering and in process equipment’s to the pharmaceutical, biotech, life sciences and other industries, will display its expertise in modular construction, facility engineering and process design at the important ISPE 2017 Europe Annual Conference in Barcelona.
Pharmadule is now accepting bookings for face-to-face meetings with its team at ISPE 2017, where it will present the company’s impressive portfolio of facility engineering, process equipment’s, quality by design (QbD), regulatory compliance and other disciplines.
Innovative process solutions
It will demonstrate Pharmadule Morimatsu’s global leadership in the delivering innovative process equipment solutions including design and fabrication of vessels, bioreactors, heat exchangers, solution prep and CIP skids and assemblies together with modular project delivery.
Together, these strengths have helped Pharmadule win several landmark orders over the past few months as it enters its 30th Anniversary year, including recent commissions for design studies in China and an order to produce designs for fast-moving consumer goods (FMCG) modular production facilities at two different global locations.
Industry 4.0 expertise
“We’re looking forward to meeting leading pharmaceutical engineering specialists and decision makers in Barcelona to discuss our process equipment’s solution and provide them with deeper and more detailed information about our capabilities,” commented Leo Fällgren, Pharmadule Morimatsu Director for Business Development.
“We’re particularly excited by this year’s ISPE Europe focus on ‘Pharma Manufacturing 2025’ and new ways to achieve a modern, agile and flexible production landscape. This will include consideration of global regulations and ‘Industry 4.0’ complete digitalized operations and full automation – both fields in which Pharmadule is a world leader,” added Mr. Fällgren.
About Pharmadule Morimatsu
Pharmadule Morimatsu designs and builds turnkey production facilities and process equipment’s for the pharma – biopharma Industries and also for the FMCG area (Fast Moving Consumer Goods). Pharmadule services extend from conceptual design to IQOQ qualifications completion, offering a one-stop-shop suite of services that include: Front-End Design & Pre-Engineering, Detailed Design, Fabrication, Quality Assurance (QA) and Validation Management.
The company was founded in September 1986 by engineer Clas Wallenborg whose vision was to use the same basic modular design techniques and technology used to build specialized spaces for offshore oil platforms to be able to deliver ‘ready made’ hygienic pharmaceutical production and laboratory facilities worldwide. These could be designed and fabricated centrally under hi-tech controlled conditions and transported to pharma sites all over the world for final assembly and erection.
Since then, Pharmadule has successfully delivered more than 60 production facilities worldwide for clients including Eli Lilly, Merck, Baxter, GlaxoSmithKline, Genentech, Pharmacia and AstraZeneca, forging The Pharmadule Way as a way of offering unique value and reassurance to customers, with off-site construction and modular design concepts to provide very high predictability of on time, on budget delivery and consistent high quality, regardless of final location.
Since 2011, Pharmadule has been part of the Morimatsu Group of Japan – specialized in process equipments, forming Pharmadule Morimatsu AB, headquartered in Stockholm, Sweden. The company also has a strong presence in Asia with engineering and manufacturing facilities in Shanghai, providing an enhanced service for clients in new markets.
About ISPE Europe 2017
ISPE, the International Society for Pharmaceutical Engineering, is one of the world’s largest not-for-profit associations, committed to the advancement of the efficiency of its members through exchange of ideas and practical experience. Founded in 1980, the Society now numbers more than 20,000 members in 90 countries.
ISPE Europe 2017 is a three-day event opening April 3 at the Crowne Plaza Hotel and Fira Center in central Barcelona.
This year’s conference has attracted more than 1,500 delegates from some 30 countries, along with more than 100 exhibitors.
ISPE 2017 Europe will focus on “Pharma Manufacturing 2025” and routes to a modern, agile, and flexible production landscape, confronting issues such as main regulatory trends, evolution of technology platforms, required skillsets and capabilities and the shape of future facilities and process management.
The event is organized by iSpeak in partnership with Pharmaceutical Engineering magazine, with more information at: http://www.ispe.org/2017-europe-annual-conference
Leo Fällgren, Director Business Development, Pharmadule Morimatsu AB
Tel: +46 (0)8 587 42 000